NEWLINK GENETICS CORP's ticker is NLNK and the CUSIP is 651511107. A total of 109 filers reported holding NEWLINK GENETICS CORP in Q2 2018. The put-call ratio across all filers is 1.64 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $3,000 | +50.0% | 1,000 | 0.0% | 0.00% | – |
Q3 2019 | $2,000 | +100.0% | 1,000 | 0.0% | 0.00% | – |
Q2 2019 | $1,000 | -50.0% | 1,000 | 0.0% | 0.00% | – |
Q1 2019 | $2,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q4 2018 | $2,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q3 2018 | $2,000 | -60.0% | 1,000 | 0.0% | 0.00% | – |
Q2 2018 | $5,000 | -28.6% | 1,000 | 0.0% | 0.00% | – |
Q1 2018 | $7,000 | -12.5% | 1,000 | 0.0% | 0.00% | – |
Q4 2017 | $8,000 | -20.0% | 1,000 | 0.0% | 0.00% | – |
Q3 2017 | $10,000 | +42.9% | 1,000 | 0.0% | 0.00% | – |
Q2 2017 | $7,000 | -70.8% | 1,000 | 0.0% | 0.00% | – |
Q1 2017 | $24,000 | +140.0% | 1,000 | 0.0% | 0.00% | – |
Q4 2016 | $10,000 | -33.3% | 1,000 | 0.0% | 0.00% | – |
Q3 2016 | $15,000 | +36.4% | 1,000 | 0.0% | 0.00% | – |
Q2 2016 | $11,000 | -38.9% | 1,000 | 0.0% | 0.00% | – |
Q1 2016 | $18,000 | -50.0% | 1,000 | 0.0% | 0.00% | – |
Q4 2015 | $36,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q3 2015 | $36,000 | – | 1,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 93,533 | $962,000 | 1.69% |
WALL STREET ASSOCIATES | 108,900 | $1,119,000 | 0.74% |
NORTHWEST WEALTH MANAGEMENT, LLC | 57,482 | $591,000 | 0.60% |
Orbimed Advisors | 1,991,700 | $20,475,000 | 0.26% |
TFS CAPITAL LLC | 92,041 | $946,000 | 0.25% |
Intrinsic Edge Capital Management LLC | 40,000 | $411,000 | 0.18% |
SECOR Capital Advisors, LP | 100,529 | $1,033,000 | 0.13% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 176,077 | $1,810,000 | 0.12% |
Piermont Capital Management Inc. | 41,400 | $426,000 | 0.10% |
Vident Investment Advisory, LLC | 67,209 | $691,000 | 0.08% |